Clinical Trials on Mucosal Lentiginous Melanoma
Total 3532 results
-
Hoffmann-La RocheCompleted
-
Hadassah Medical OrganizationUnknown
-
Merck Sharp & Dohme LLCTerminated
-
Hoffmann-La RocheCompletedMalignant MelanomaItaly, United Kingdom, Belgium, Poland, Netherlands, Germany, Austria, Czechia, Ireland, Sweden
-
Eli Lilly and CompanyCompletedMetastatic MelanomaAustralia, United States
-
John P. FruehaufBayerCompletedMetastatic MelanomaUnited States
-
American Regent, Inc.Completed
-
CelgeneNYU Langone Health; Syneos Health; Celerion; ApoCell, Inc.CompletedMalignant MelanomaUnited States
-
Western Regional Medical CenterWithdrawnMetastatic MelanomaUnited States
-
John KirkwoodNational Cancer Institute (NCI); National Institutes of Health (NIH)Terminated
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLCWithdrawn
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
National Human Genome Research Institute (NHGRI)Completed
-
University of IowaNovartis Pharmaceuticals; Holden Comprehensive Cancer CenterTerminatedMetastatic MelanomaUnited States
-
Centre Hospitalier Universitaire, AmiensUnknown
-
Beth Israel Deaconess Medical CenterGenzyme, a Sanofi CompanyCompletedMetastatic MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Gene Vector LaboratoryCompletedMalignant MelanomaUnited States
-
Genentech, Inc.CompletedMalignant MelanomaUnited States, Australia
-
Hoffmann-La RocheTerminatedMalignant MelanomaUnited States, France, Australia, United Kingdom, Italy, Spain, Germany, Israel, Poland, Slovakia
-
University of ZurichCompleted
-
University of PittsburghBristol-Myers SquibbWithdrawn
-
AVAX TechnologiesTerminatedMelanoma (Skin)United States
-
Italian Network for Tumor Biotherapy FoundationAstex Pharmaceuticals, Inc.Unknown
-
Laboratorio Pablo Cassará S.R.L.National Council of Scientific and Technical Research, Argentina; Fundacion... and other collaboratorsUnknownCutaneous MelanomaArgentina
-
Hadassah Medical OrganizationCompletedMetastatic MelanomaIsrael
-
Cancer Trials IrelandCompletedMelanoma (Skin)Ireland
-
Oslo University HospitalCompleted
-
James Graham Brown Cancer CenterUniversity of LouisvilleCompleted
-
Yonsei UniversityCompleted
-
Bristol-Myers SquibbMedarexCompletedAdvanced MelanomaUnited States
-
Ludwig Institute for Cancer ResearchAgonOxWithdrawn
-
California Pacific Medical Center Research InstitutePfizer; University of California, San FranciscoCompleted
-
Philogen S.p.A.Eudax S.r.l.TerminatedMetastatic MelanomaSwitzerland, Italy, Austria, Germany
-
Bristol-Myers SquibbMedarexCompleted
-
SciBase ABCompleted
-
University of ChicagoCompletedMetastatic MelanomaUnited States
-
University of Colorado, DenverNational Cancer Institute (NCI)Completed
-
Hackensack Meridian HealthNational Cancer Institute (NCI)WithdrawnMelanoma (Skin)United States
-
Providence Health & ServicesWithdrawn
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)WithdrawnMelanoma (Skin)United States
-
Sheba Medical CenterUnknownMetastatic MelanomaIsrael
-
Astellas Pharma IncOSI Pharmaceuticals; Cell PathwaysTerminated
-
Memorial Sloan Kettering Cancer CenterYale University; University of New MexicoCompleted
-
AmpliMed CorporationCompletedMalignant MelanomaUnited States
-
Myrexis Inc.Completed
-
Bristol-Myers SquibbCompletedMetastatic MelanomaUnited States
-
Eli Lilly and CompanyMemorial Sloan Kettering Cancer CenterCompleted